Editorial Article
How Leading Scientists in Italy are Performing State-of-the-Art Cell-Based Assays to Help Push Boundaries in Anticancer Drug Discovery
Aiding access to automation in cancer research
Aiding access to automation in cancer research
Dream big, don’t be limited by current opinion and don’t be afraid to make mistakes – co-CEO Dr. Stefan Duhr shares his tips for success and more
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
Learn how the team at NanoTemper Technologies is helping scientists design better assays and quickly generate meaningful results
SelectScience is excited to be attending AACR 2017, Washington D.C., USA
Global leaders convene to map new paths to diagnose and treat Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases that afflict one in six people